SAN DIEGO, CA — (Marketwired) — 08/13/13 — (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced a leadership reorganization beginning with the return of Dave Pfanzelter as chairman of the board of directors. Mr. Pfanzelter will also serve as interim chief executive officer while the company initiates the process of recruiting a new CEO. The company-s former chief financial officer, Peter C. Wulff, also agreed to return to the company to serve
PURE Hard Surface Reduced Overall Contamination 96% Better Than Current -Quat- Ammonia Sanitizer, Supporting Laboratory Studies of Greater Than 99.999% Reduction in Microbial Counts
PURE Products Now REACH Pre-Registered, Authorizing TICE to Import and Distribute PURE Products Across Europe
